Q1 2020 Catalyst Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to the Catalyst Pharmaceuticals First Quarter 2020 Results Conference. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Ali Grande, CFO.
Thank you. You may begin.
Good morning, everyone, and welcome to today's conference call. Joining me on today's call are members of the Catalyst team, including Patrick McEnany, Chairman and Chief Executive Officer; Dr. Steven Miller, Chief Operating Officer and Chief Scientific Officer; Dr. Gary Ingenito, Chief Medical Officer and Head of Regulatory Affairs; and Dan Brennan, Chief Commercial Officer.
Before we begin, I would like to remind you that in the following comments, and in the Q&A session, we will make statements about expected future results, which may be forward-looking statements for purposes of federal securities laws. These statements relate to our current expectations, estimates and projections and are not
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |